Pediatrics. 2021 Oct;148(4). doi: 10.1542/peds.2021-053745. Epub 2021 Sep 7.
This technical report accompanies the recommendations of the American Academy of Pediatrics for the routine use of the influenza vaccine and antiviral medications in the prevention and treatment of influenza in children during the 2021-2022 season. Influenza vaccination is an important intervention to protect vulnerable populations and reduce the burden of respiratory illnesses during circulation of severe acute respiratory syndrome coronavirus 2, which is expected to continue during this influenza season. In this technical report, we summarize recent influenza seasons, morbidity and mortality in children, vaccine effectiveness, vaccination coverage, and detailed guidance on storage, administration, and implementation. We also provide background on inactivated and live attenuated influenza vaccine recommendations, vaccination during pregnancy and breastfeeding, diagnostic testing, and antiviral medications for treatment and chemoprophylaxis.
本技术报告是对美国儿科学会关于在 2021-2022 季节常规使用流感疫苗和抗病毒药物预防和治疗儿童流感的建议的补充。流感疫苗接种是保护弱势群体和减轻严重急性呼吸综合征冠状病毒 2 传播期间呼吸道疾病负担的重要干预措施，预计在本流感季节仍将继续。在本技术报告中，我们总结了最近的流感季节、儿童发病率和死亡率、疫苗有效性、疫苗接种率以及关于储存、管理和实施的详细指导。我们还提供了关于灭活和减毒流感疫苗推荐、妊娠和哺乳期接种、诊断检测以及治疗和化学预防用抗病毒药物的背景信息。
